L01XC: Monoclonal antibodies

Explore L01XC Monoclonal antibodies in the ATC classification system. Part of L Antineoplastic and Immunomodulating Agents > L01 Antineoplastic Agents > L01X...

About Monoclonal antibodies

L01XC Monoclonal antibodies is part of the WHO ATC classification system and belongs to L Antineoplastic and Immunomodulating Agents > L01 Antineoplastic Agents > L01X Other Antineoplastic Agents. This chemical subgroup page helps users identify more specific classifications and related active ingredients associated with this ATC code. It also includes 38 related active ingredients, supporting deeper navigation across ingredient-level pages. Use this page to explore the ATC hierarchy, review connected groups, and find relevant ingredient pages within Pharmassive.

Active Ingredients in Monoclonal antibodies

Alemtuzumab

View ingredient details →

 Atezolizumab

View ingredient details →

 Avelumab

View ingredient details →

 Belantamab Mafodotin

View ingredient details →

 Bermekimab

View ingredient details →

 Bevacizumab

View ingredient details →

 Blinatumomab

View ingredient details →

 Brentuximab Vedotin

View ingredient details →

 Catumaxomab

View ingredient details →

 Cemiplimab

View ingredient details →

 Cetuximab

View ingredient details →

 Daratumumab

View ingredient details →

 Dinutuximab Beta

View ingredient details →

 Dostarlimab

View ingredient details →

 Durvalumab

View ingredient details →

 Edrecolomab

View ingredient details →

 Elotuzumab

View ingredient details →

 Enfortumab Vedotin

View ingredient details →

 Gemtuzumab Ozogamicin

View ingredient details →

 Inotuzumab Ozogamicin

View ingredient details →

 Ipilimumab

View ingredient details →

 Isatuximab

View ingredient details →

 Mogamulizumab

View ingredient details →

 Moxetumomab Pasudotox

View ingredient details →

 Necitumumab

View ingredient details →

 Nivolumab

View ingredient details →

 Obinutuzumab

View ingredient details →

 Ofatumumab

View ingredient details →

 Olaratumab

View ingredient details →

 Panitumumab

View ingredient details →

 Pembrolizumab

View ingredient details →

 Pertuzumab

View ingredient details →

 Polatuzumab Vedotin

View ingredient details →

 Ramucirumab

View ingredient details →

 Rituximab

View ingredient details →

 Tafasitamab

View ingredient details →

 Trastuzumab

View ingredient details →

 Trastuzumab Emtansin

View ingredient details →